Accordingly, it was experimentally demonstrated that increased expression of ICAM-1 on the lung of NOD/scid mice after ATRA therapy is important for the pulmonary infiltration of APL cells [10]. The gene discussed is ICAM1; the disease is acute promyelocytic leukemia.